Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avantor (AVTR) Asset Writedowns and Impairment (2023 - 2025)

Avantor's quarterly Asset Writedowns and Impairment came in at $785.0 million in Q3 2025, up 637.78% quarter-over-quarter from $106.4 million in Q2 2024.

Avantor has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $785.0 million in Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $785.0 million; the trailing twelve-month figure through Dec 2025 stood at $785.0 million (up 637.78% YoY), and the FY2025 full-year result was $785.0 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 stood at $785.0 million, up from $106.4 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $785.0 million in Q3 2025, with the low at $54.4 million in Q2 2023.
  • Average Asset Writedowns and Impairment over 3 years is $315.3 million, with a median of $106.4 million recorded in 2024.
  • Peak annual rise in Asset Writedowns and Impairment reached 95.59% in 2024, while the deepest fall reached 95.59% in 2024.
  • Tracing AVTR's Asset Writedowns and Impairment over 3 years: stood at $54.4 million in 2023, then surged by 95.59% to $106.4 million in 2024, then surged by 637.78% to $785.0 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $785.0 million (Q3 2025), $106.4 million (Q2 2024), and $54.4 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Avantor 5.31 Bn 5.03 Bn 500.70 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 785.00 Mn
Sep 30, 2025 785.00 Mn
Jun 30, 2024 106.40 Mn
Jun 30, 2024 106.40 Mn
Jun 30, 2023 54.40 Mn
Jun 30, 2023 54.40 Mn